jag009
★★★

NJ,
2015-05-02 09:27
(3615 d 08:40 ago)

Posting: # 14746
Views: 11,649
 

 Q1 / Q2 Guidance FDA [Regulatives / Guidelines]

Hi,

Does anyone know if there is some kind of FDA guidance on Q1 and Q2? I searched around and only find bits and pieces of information...

Thanks

John
luvblooms
★★  

India,
2015-05-04 08:55
(3613 d 09:13 ago)

@ jag009
Posting: # 14747
Views: 10,468
 

 Q1 / Q2: CFR 320 may be of some help

Hi John


❝ Does anyone know if there is some kind of FDA guidance on Q1 and Q2? I searched around and only find bits and pieces of information...


As of now even I am not aware of any specific Q1/Q2 guidance but there are sufficient information available in CFR's.

Do check these links
  1. Excipients: A Regulatory Support Prospective: Many CFR links are given for Solution, opthalmics and injections

  2. Criteria for waiver of evidence of in vivo bioavailability or bioequivalence.

  3. 21 CFR 320.22 - Criteria for waiver of evidence of in vivo bioavailability or bioequivalence

Hope this would be of some help!!!

~A happy Soul~
jag009
★★★

NJ,
2015-05-05 00:54
(3612 d 17:14 ago)

@ luvblooms
Posting: # 14748
Views: 10,162
 

 Q1 / Q2: CFR 320 may be of some help

Thanks Bloom,

Yes I found those info as well.

John
nobody
nothing

2015-05-05 13:19
(3612 d 04:48 ago)

@ jag009
Posting: # 14749
Views: 10,133
 

 Q1 / Q2: CFR 320 may be of some help


Kindest regards, nobody
UA Flag
Activity
 Admin contact
23,409 posts in 4,921 threads, 1,714 registered users;
21 visitors (0 registered, 21 guests [including 8 identified bots]).
Forum time: 17:08 CET (Europe/Vienna)

It’s easy to lie with statistics;
it is easier to lie without them.    Frederick Mosteller

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5